This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pompei, F. Articles by Wilson, R. Search for Related Content PubMed PubMed Citation Articles by Pompei, F. Articles by Wilson, R. Social Bookmarking                         What's this?

Age distribution of cancer in mice: the incidence turnover at old age

Division of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, USA, fpompei{at}post.harvard.edu

Michael Polkanov

Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA

Richard Wilson

Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA

We have studied cancer incidence in mice as a function of age in those cohorts where the rodents are allowed to live very close to their full natural lifetime. We find that the incidence rises as a function of age, but then flattens and turns over at an age of about 800 days. This behaviour is similar to that which we observed (Pompei and Wilson, 2001) in the Surveillance, Epidemiology, and End Results (SEER) data where the age distribution of human cancer incidence turns over at about age 80. Although other fits are possible, the three-parameter beta function model fits both the mouse data and the human data well. The beta model implies, and the data do not deny, the interpretation that cancer is not a certainty and mice may also outlive their cancers, although high-dose cohort results suggest cancer might be certain if dose is sufficiently high. Limited data suggest that the cancer age distribution, including the turnover, may be time shifted by dietary restriction.

Key Words: age • cancer cell senescence • cancer incidence • cancer model • dietary restriction

Toxicology and Industrial Health, Vol. 17, No. 1, 7-16 (2001)
DOI: 10.1191/0748233701th091oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. P. Boscoe Subdividing the Age Group of 85 Years and Older to Improve US Disease Reporting Am J Public Health, July 1, 2008; 98(7): 1167 - 1170. [Abstract] [Full Text] [PDF]

				C. Harding, F. Pompei, E. E. Lee, and R. Wilson Cancer Suppression at Old Age Cancer Res., June 1, 2008; 68(11): 4465 - 4478. [Abstract] [Full Text] [PDF]

				M. A. Vickers JAK2 617V>F positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation Blood, September 1, 2007; 110(5): 1675 - 1680. [Abstract] [Full Text] [PDF]

				D. C. Cabelof, Y. Ikeno, A. Nyska, R. A. Busuttil, N. Anyangwe, J. Vijg, L. H. Matherly, J. D. Tucker, S. H. Wilson, A. Richardson, et al. Haploinsufficiency in DNA Polymerase {beta} Increases Cancer Risk with Age and Alters Mortality Rate. Cancer Res., August 1, 2006; 66(15): 7460 - 7465. [Abstract] [Full Text] [PDF]

				F. Pompei and R. Wilson A quantitative model of cellular senescence influence on cancer and longevity Toxicology and Industrial Health, September 1, 2002; 18(8): 365 - 376. [Abstract] [PDF]